426 related articles for article (PubMed ID: 31239369)
41. Molecular genetics in classic Ehlers-Danlos syndrome.
Malfait F; De Paepe A
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
[TBL] [Abstract][Full Text] [Related]
42. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.
Malfait F; Wenstrup RJ; De Paepe A
Genet Med; 2010 Oct; 12(10):597-605. PubMed ID: 20847697
[TBL] [Abstract][Full Text] [Related]
43. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
Giunta C; Steinmann B
Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
[TBL] [Abstract][Full Text] [Related]
44. Osteogenesis imperfecta type III/Ehlers-Danlos overlap syndrome in a Chinese man.
Lu Y; Wang Y; Rauch F; Li H; Zhang Y; Zhai N; Zhang J; Ren X; Han J
Intractable Rare Dis Res; 2018 Feb; 7(1):37-41. PubMed ID: 29552444
[TBL] [Abstract][Full Text] [Related]
45. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
[TBL] [Abstract][Full Text] [Related]
46. A novel arginine-to-cysteine substitution in the triple helical region of the alpha1(I) collagen chain in a family with an osteogenesis imperfecta/Ehlers-Danlos phenotype.
Lund A; Joensen F; Christensen E; Dunø M; Skovby F; Schwartz M
Clin Genet; 2008 Jan; 73(1):97-101. PubMed ID: 18028452
[No Abstract] [Full Text] [Related]
47. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
[TBL] [Abstract][Full Text] [Related]
48. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.
Liu Y; Asan ; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Xing X; Yu W; Wang J; Sun J; Song L; Zhu Y; Yang H; Wang J; Li M
Osteoporos Int; 2017 Oct; 28(10):2985-2995. PubMed ID: 28725987
[TBL] [Abstract][Full Text] [Related]
49. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
Ho Duy B; Zhytnik L; Maasalu K; Kändla I; Prans E; Reimann E; Märtson A; Kõks S
Hum Genomics; 2016 Aug; 10(1):27. PubMed ID: 27519266
[TBL] [Abstract][Full Text] [Related]
50. [A new mutation in COL1A1 gene in a family with osteogenesis imperfecta].
Wang Z; Xu DL; Chen Z; Hu JY; Yang Z; Wang LT
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):170-3. PubMed ID: 16638323
[TBL] [Abstract][Full Text] [Related]
51. IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.
Zhytnik L; Maasalu K; Duy BH; Pashenko A; Khmyzov S; Reimann E; Prans E; Kõks S; Märtson A
Hum Genomics; 2019 Jun; 13(1):25. PubMed ID: 31159867
[TBL] [Abstract][Full Text] [Related]
52. A novel variant of osteogenesis imperfecta type IV and low serum phosphorus level caused by a Val94Asp mutation in COL1A1.
Yang Q; Xu H; Luo J; Zhang Q; Xie B; Yi S; Rong X; Wang J; Qin Z; Jiang T; Lin L; Zuo Y; Fan X
Mol Med Rep; 2018 Mar; 17(3):4433-4439. PubMed ID: 29344653
[TBL] [Abstract][Full Text] [Related]
53. Craniofacial and Dental Defects in the Col1a1Jrt/+ Mouse Model of Osteogenesis Imperfecta.
Eimar H; Tamimi F; Retrouvey JM; Rauch F; Aubin JE; McKee MD
J Dent Res; 2016 Jul; 95(7):761-8. PubMed ID: 26951553
[TBL] [Abstract][Full Text] [Related]
54. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients.
Zhytnik L; Maasalu K; Reimann E; Prans E; Kõks S; Märtson A
Hum Genomics; 2017 Aug; 11(1):19. PubMed ID: 28810924
[TBL] [Abstract][Full Text] [Related]
55. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.
Nicholls AC; Oliver JE; McCarron S; Harrison JB; Greenspan DS; Pope FM
J Med Genet; 1996 Nov; 33(11):940-6. PubMed ID: 8950675
[TBL] [Abstract][Full Text] [Related]
56. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.
Ritelli M; Dordoni C; Venturini M; Chiarelli N; Quinzani S; Traversa M; Zoppi N; Vascellaro A; Wischmeijer A; Manfredini E; Garavelli L; Calzavara-Pinton P; Colombi M
Orphanet J Rare Dis; 2013 Apr; 8():58. PubMed ID: 23587214
[TBL] [Abstract][Full Text] [Related]
57. Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.
Galicka A; Wołczyński S; Gindzieński A; Surazyński A; Pałka J
Mol Cell Biochem; 2003 Jun; 248(1-2):49-56. PubMed ID: 12870654
[TBL] [Abstract][Full Text] [Related]
58. An in vitro model to evaluate the properties of matrices produced by fibroblasts from osteogenesis imperfecta and Ehlers-Danlos Syndrome patients.
Micha D; Pals G; Smit TH; Ghazanfari S
Biochem Biophys Res Commun; 2020 Jan; 521(2):310-317. PubMed ID: 31668813
[TBL] [Abstract][Full Text] [Related]
59. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.
De Paepe A; Nuytinck L; Hausser I; Anton-Lamprecht I; Naeyaert JM
Am J Hum Genet; 1997 Mar; 60(3):547-54. PubMed ID: 9042913
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of COL1A1 gene mutation in an ethnic Han Chinese family from Henan affected with osteogenesis imperfecta].
Huang Y; Guo L; Wang D; Yang M; Yang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):653-6. PubMed ID: 27577215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
